Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06300866 · ClinicalTrials.gov registry record · Phase 3

Gingivitis Reduction After Use of 0.45% Stannous Fluoride Toothpaste

A Phase 3 study of Gingivitis and Plaque, Dental, sponsored by Colgate Palmolive.

Completed
Registry status
Phase 3
Development phase
80
Enrollment target
1
Study location

NCT06300866: Completed Phase 3 study of Gingivitis and Plaque, Dental, sponsored by Colgate Palmolive.

NCT06300866 is a Phase 3 study of Gingivitis and Plaque, Dental that has completed, run by Colgate Palmolive. The registered enrollment target is 80 participants, below the 233-participant average among 25 other Gingivitis trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06300866, a Phase 3 study of Gingivitis and Plaque, Dental, has completed, sponsored by Colgate Palmolive.

COMPLETED
Registry status
Phase 3
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

The 6-month clinical study was designed to investigate clinical efficacy on plaque and gingivitis for the stannous fluoride containing toothpaste (SNAP) compared to Colgate Cavity Protection Toothpaste after 3 and 6 months of product use.

Primary Outcome

difference of reduction in gingival index

Interventions

  • DRUG Control
  • DRUG Test

Study Locations (1)

California

  • Loma Linda University School of Dentistry - Loma Linda

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2020-08-18
Est. Completion 2021-03-08
Phase Phase 3
Colgate Palmolive

51 total trials

What the finished NCT06300866 record still lists

NCT06300866 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 233-participant average among 25 other Gingivitis trials with a reported enrollment target (66% lower).

The record links to 2 conditions, with Gingivitis appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.

NCT06300866 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06300866 about?

NCT06300866 is a clinical study titled "Gingivitis Reduction After Use of 0.45% Stannous Fluoride Toothpaste". The 6-month clinical study was designed to investigate clinical efficacy on plaque and gingivitis for the stannous fluoride containing toothpaste (SNAP) compared to Colgate Cavity Protection Toothpaste after 3 and 6 months of product use.

What is the current status of trial NCT06300866?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 80 participants. The study started on 2020-08-18. Estimated completion is 2021-03-08.

What conditions does trial NCT06300866 study?

This clinical trial studies the following conditions: Gingivitis, Plaque, Dental.

What interventions are being tested in trial NCT06300866?

The interventions under investigation include: Control (DRUG), Test (DRUG).

Who is sponsoring clinical trial NCT06300866?

This trial is sponsored by Colgate Palmolive, which has 51 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06300866 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gingivitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06300866's enrollment target sits among peer trials

80 19th of 25 higher than 6 of 25 other Gingivitis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Gingivitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06300866, the US trial registry maintained by the National Library of Medicine. NCT06300866 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.